Press Releases Year None20232022202120202019201820172016 Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference May 31, 2023 PDF Version View HTML Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting May 31, 2023 PDF Version View HTML Gamida Cell Appoints Terry Coelho as CFO May 22, 2023 PDF Version View HTML Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update May 15, 2023 PDF Version View HTML Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast May 11, 2023 PDF Version View HTML Gamida Cell Announces Pricing of $23 Million Public Offering of Securities April 19, 2023 PDF Version View HTML Gamida Cell Announces Launch of Public Offering of Securities April 18, 2023 PDF Version View HTML Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval April 17, 2023 PDF Version View HTML Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update March 27, 2023 PDF Version View HTML Gamida Cell Announces Changes to Board of Directors March 20, 2023 PDF Version View HTML Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13
